News about "Moderna, Medison Pharma ink agreement "

Moderna, Medison Pharma ink agreement to commercialize Moderna's Covid-19 vaccine across Central Eastern Europe & Israel

Moderna, Medison Pharma ink agreement to commercialize Moderna's Covid-19 vaccine across Central Eastern Europe & Israel

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the Moderna Covid-19 vaccine across Central Eastern Europe and Israel

Moderna, Medison Pharma Ink Agreement | 08/06/2021 | By Darshana 147


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members